Baker Brothers Advisors

Baker Brothers Advisors is a New York-based hedge fund management firm that specializes in strategic, long-term investments within the biotechnology sector. The firm employs a highly specialized investment approach, deeply integrating scientific understanding with financial acumen to identify and cultivate promising biopharmaceutical companies, often taking active roles through board representation to guide their development.

The firm was founded in 2000 by brothers Felix Baker and Julian Baker. Prior to establishing their own venture, the brothers gained significant experience managing healthcare investments for the Laurence Tisch family starting in 1994. Felix, holding a PhD in immunology and a background in biology from Stanford, complemented Julian's expertise in private equity and social studies from Harvard, forming a distinctive blend of scientific and financial insight that underpins their investment philosophy.

Baker Brothers Advisors serves a discerning client base of institutional investors who seek specialized exposure to the biotechnology landscape. The firm's vision centers on capitalizing on and contributing to scientific advances, particularly in genetics, and the ongoing evolution of the biopharmaceutical industry through meticulous research and active partnership with innovative companies, aiming to generate substantial value over extended periods.